Inventor
PANG IOK-HOU
US19 patents
⚠️ This page may combine multiple inventors who share the name “PANG IOK-HOU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALCON INC
7 patentsUS7838507B2Nov 23, 2010
RNAi inhibition of CTGF for treatment of ocular disorders
ALCON INC13 citations81
US7622454B2Nov 24, 2009
RNAi inhibition of CTGF for treatment of ocular disorders
ALCON INC10 citations81
US7598288B2Oct 6, 2009
Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
ALCON INC17 citations81
US7351407B2Apr 1, 2008
Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
ALCON INC13 citations76
US7384926B2Jun 10, 2008
Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
ALCON INC0 citations52
US7488723B2Feb 10, 2009
Use of non-feminizing estrogens as treatment for retinal vascular diseases
ALCON INC0 citations51
US7803824B2Sep 28, 2010
Use of inhibitors of Jun N-terminal kinases to treat glaucoma
ALCON INC1 citations47
ALCON LAB INC
3 patentsUS5681854AOct 28, 1997
Use of aliphatic carboxylic acid derivatives in ophthalmic disorders
ALCON LAB INC23 citations92
US6303579B1Oct 16, 2001
Use of calpain inhibitors to treat ocular neural pathology
ALCON LAB INC11 citations73
US5965534AOct 12, 1999
Use of ω-conotoxin analogs for treating retinal and optic nerve head damage
ALCON LAB INC0 citations44
ALCON MFG LTD
3 patentsUS6906077B1Jun 14, 2005
Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
ALCON MFG LTD2 citations62
US7005446B1Feb 28, 2006
Use of AP-1 activators to treat glaucoma and ocular hypertension
ALCON MFG LTD2 citations60
US6399058B1Jun 4, 2002
Methods for treating ocular diseases
ALCON MFG LTD0 citations51